Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ACLX
Stock Latest News
Company Announcements
Arcellx Inc Announces Board Changes for Strategic Growth
6d ago
8K
ACLX
Premium
Ratings
Optimistic Buy Rating for Arcellx Inc: Promising CAR-T Therapy and Strong Financial Position Highlighted
23d ago
ACLX
Premium
Company Announcements
Arcellx Reports Promising 2024 Financial and Clinical Progress
25d ago
ACLX
Premium
Ratings
Arcellx Inc’s Anito-cel: Anticipated Market Leader with Strong Efficacy, Safety, and Financial Position
26d ago
ACLX
Premium
Ratings
Arcellx Inc: Buy Rating Affirmed on Promising Anito-cel Therapy and Strong Financial Position
26d ago
ACLX
Premium
Ratings
Arcellx Inc’s Anito-cel Therapy: Promising Clinical Results and Strategic Partnerships Support Buy Rating
26d ago
ACLX
Premium
Ratings
Arcellx Inc’s Anito-cel: Promising Performance and Positive Outlook with Buy Rating
26d ago
ACLX
Premium
The Fly
Arcellx reports FY24 EPS ($2.00), consensus ($1.50)
27d ago
ACLX
Premium
Ratings
Arcellx Inc’s Anito-cel: A Promising Investment with Innovative Therapeutics and Market Potential
1M ago
ACLX
Premium
The Fly
Opco lists five potential biotech targets into JPMorgan conference
3M ago
XBI
ACLX
Premium
The Fly
Arcellx price target raised to $114 from $106 at UBS
4M ago
ACLX
LEGN
Premium
The Fly
Gilead price target raised to $115 from $105 at Oppenheimer
4M ago
JNJ
ACLX
Premium
The Fly
Arcellx, Gilead announce new data from iMMagine-1 study of anitocabtagene autole
4M ago
ACLX
GILD
Premium
The Fly
Arcellx price target raised to $115 from $73 at Barclays
4M ago
ACLX
Premium
Company Announcements
Arcellx, Inc. Reports Q3 2024 Earnings Highlights
4M ago
ACLX
Premium
The Fly
Arcellx price target raised to $136 from $87 at Truist
4M ago
ACLX
Premium
The Fly
Arcellx price target raised to $133 from $82 at Scotiabank
4M ago
ACLX
Premium
The Fly
Arcellx price target raised to $115 from $91 at Piper Sandler
5M ago
ACLX
Premium
The Fly
Arcellx reports Q3 EPS (48c), consensus (43c)
5M ago
ACLX
Premium
The Fly
Arcellx price target raised to $106 from $77 at Baird
5M ago
ACLX
Premium
The Fly
Arcellx price target raised to $106 from $81 at Morgan Stanley
5M ago
ACLX
Premium
The Fly
Arcellx price target raised to $100 from $84 at BofA
5M ago
ACLX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
